aluates Reports

$ 0.0

Automative

Global Nontuberculous Mycobacterium Treatment Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-17B10487

Global Nontuberculous Mycobacterium Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Nontuberculous Mycobacterium Treatment Market Research Report 2025

Code: QYRE-Auto-17B10487

Report

June 2025

Pages:68

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Insmed Incorporated

RedHill Biopharma

Novoteris

Savara

Beyond Air

Nontuberculous Mycobacterium Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nontuberculous Mycobacterium Treatment Market

The global market for Nontuberculous Mycobacterium Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nontuberculous Mycobacterium Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nontuberculous Mycobacterium Treatment.

The Nontuberculous Mycobacterium Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nontuberculous Mycobacterium Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nontuberculous Mycobacterium Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nontuberculous Mycobacterium Treatment Market Report

Report Metric	Details
Report Name	Nontuberculous Mycobacterium Treatment Market
CAGR	5%
Segment by Type	Azithromycin Rifampin Rifabutin Ethambuto
Segment by Application	Hospitals Pharmacies Private clinics Drug Stores and Retail Pharmacy E-commerce
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Insmed Incorporated, RedHill Biopharma, Novoteris, Savara, Beyond Air
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nontuberculous Mycobacterium Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nontuberculous Mycobacterium Treatment Market report?

Ans: The main players in the Nontuberculous Mycobacterium Treatment Market are Insmed Incorporated, RedHill Biopharma, Novoteris, Savara, Beyond Air

What are the Application segmentation covered in the Nontuberculous Mycobacterium Treatment Market report?

Ans: The Applications covered in the Nontuberculous Mycobacterium Treatment Market report are Hospitals Pharmacies, Private clinics, Drug Stores and Retail Pharmacy, E-commerce

What are the Type segmentation covered in the Nontuberculous Mycobacterium Treatment Market report?

Ans: The Types covered in the Nontuberculous Mycobacterium Treatment Market report are Azithromycin, Rifampin, Rifabutin, Ethambuto

Recommended Reports

Infectious Disease Therapy

Immune & Autoimmune Drugs

Non-Invasive & Respiratory

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Azithromycin

1.2.3 Rifampin

1.2.4 Rifabutin

1.2.5 Ethambuto

1.3 Market by Application

1.3.1 Global Nontuberculous Mycobacterium Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals Pharmacies

1.3.3 Private clinics

1.3.4 Drug Stores and Retail Pharmacy

1.3.5 E-commerce

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nontuberculous Mycobacterium Treatment Market Perspective (2020-2031)

2.2 Global Nontuberculous Mycobacterium Treatment Growth Trends by Region

2.2.1 Global Nontuberculous Mycobacterium Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nontuberculous Mycobacterium Treatment Historic Market Size by Region (2020-2025)

2.2.3 Nontuberculous Mycobacterium Treatment Forecasted Market Size by Region (2026-2031)

2.3 Nontuberculous Mycobacterium Treatment Market Dynamics

2.3.1 Nontuberculous Mycobacterium Treatment Industry Trends

2.3.2 Nontuberculous Mycobacterium Treatment Market Drivers

2.3.3 Nontuberculous Mycobacterium Treatment Market Challenges

2.3.4 Nontuberculous Mycobacterium Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nontuberculous Mycobacterium Treatment Players by Revenue

3.1.1 Global Top Nontuberculous Mycobacterium Treatment Players by Revenue (2020-2025)

3.1.2 Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Nontuberculous Mycobacterium Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nontuberculous Mycobacterium Treatment Revenue

3.4 Global Nontuberculous Mycobacterium Treatment Market Concentration Ratio

3.4.1 Global Nontuberculous Mycobacterium Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nontuberculous Mycobacterium Treatment Revenue in 2024

3.5 Global Key Players of Nontuberculous Mycobacterium Treatment Head office and Area Served

3.6 Global Key Players of Nontuberculous Mycobacterium Treatment, Product and Application

3.7 Global Key Players of Nontuberculous Mycobacterium Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nontuberculous Mycobacterium Treatment Breakdown Data by Type

4.1 Global Nontuberculous Mycobacterium Treatment Historic Market Size by Type (2020-2025)

4.2 Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Type (2026-2031)

5 Nontuberculous Mycobacterium Treatment Breakdown Data by Application

5.1 Global Nontuberculous Mycobacterium Treatment Historic Market Size by Application (2020-2025)

5.2 Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nontuberculous Mycobacterium Treatment Market Size (2020-2031)

6.2 North America Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)

6.4 North America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nontuberculous Mycobacterium Treatment Market Size (2020-2031)

7.2 Europe Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)

7.4 Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size (2020-2031)

8.2 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nontuberculous Mycobacterium Treatment Market Size (2020-2031)

9.2 Latin America Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)

9.4 Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size (2020-2031)

10.2 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Insmed Incorporated

11.1.1 Insmed Incorporated Company Details

11.1.2 Insmed Incorporated Business Overview

11.1.3 Insmed Incorporated Nontuberculous Mycobacterium Treatment Introduction

11.1.4 Insmed Incorporated Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)

11.1.5 Insmed Incorporated Recent Development

11.2 RedHill Biopharma

11.2.1 RedHill Biopharma Company Details

11.2.2 RedHill Biopharma Business Overview

11.2.3 RedHill Biopharma Nontuberculous Mycobacterium Treatment Introduction

11.2.4 RedHill Biopharma Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)

11.2.5 RedHill Biopharma Recent Development

11.3 Novoteris

11.3.1 Novoteris Company Details

11.3.2 Novoteris Business Overview

11.3.3 Novoteris Nontuberculous Mycobacterium Treatment Introduction

11.3.4 Novoteris Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)

11.3.5 Novoteris Recent Development

11.4 Savara

11.4.1 Savara Company Details

11.4.2 Savara Business Overview

11.4.3 Savara Nontuberculous Mycobacterium Treatment Introduction

11.4.4 Savara Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)

11.4.5 Savara Recent Development

11.5 Beyond Air

11.5.1 Beyond Air Company Details

11.5.2 Beyond Air Business Overview

11.5.3 Beyond Air Nontuberculous Mycobacterium Treatment Introduction

11.5.4 Beyond Air Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025)

11.5.5 Beyond Air Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Insmed Incorporated

RedHill Biopharma

Novoteris

Savara

Beyond Air

List of Tables

Table 1. Global Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Azithromycin

Table 3. Key Players of Rifampin

Table 4. Key Players of Rifabutin

Table 5. Key Players of Ethambuto

Table 6. Global Nontuberculous Mycobacterium Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Nontuberculous Mycobacterium Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Nontuberculous Mycobacterium Treatment Market Share by Region (2020-2025)

Table 10. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Nontuberculous Mycobacterium Treatment Market Share by Region (2026-2031)

Table 12. Nontuberculous Mycobacterium Treatment Market Trends

Table 13. Nontuberculous Mycobacterium Treatment Market Drivers

Table 14. Nontuberculous Mycobacterium Treatment Market Challenges

Table 15. Nontuberculous Mycobacterium Treatment Market Restraints

Table 16. Global Nontuberculous Mycobacterium Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Nontuberculous Mycobacterium Treatment Market Share by Players (2020-2025)

Table 18. Global Top Nontuberculous Mycobacterium Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nontuberculous Mycobacterium Treatment as of 2024)

Table 19. Ranking of Global Top Nontuberculous Mycobacterium Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Nontuberculous Mycobacterium Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Nontuberculous Mycobacterium Treatment, Headquarters and Area Served

Table 22. Global Key Players of Nontuberculous Mycobacterium Treatment, Product and Application

Table 23. Global Key Players of Nontuberculous Mycobacterium Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Nontuberculous Mycobacterium Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global Nontuberculous Mycobacterium Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global Nontuberculous Mycobacterium Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Nontuberculous Mycobacterium Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Insmed Incorporated Company Details

Table 49. Insmed Incorporated Business Overview

Table 50. Insmed Incorporated Nontuberculous Mycobacterium Treatment Product

Table 51. Insmed Incorporated Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)

Table 52. Insmed Incorporated Recent Development

Table 53. RedHill Biopharma Company Details

Table 54. RedHill Biopharma Business Overview

Table 55. RedHill Biopharma Nontuberculous Mycobacterium Treatment Product

Table 56. RedHill Biopharma Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)

Table 57. RedHill Biopharma Recent Development

Table 58. Novoteris Company Details

Table 59. Novoteris Business Overview

Table 60. Novoteris Nontuberculous Mycobacterium Treatment Product

Table 61. Novoteris Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)

Table 62. Novoteris Recent Development

Table 63. Savara Company Details

Table 64. Savara Business Overview

Table 65. Savara Nontuberculous Mycobacterium Treatment Product

Table 66. Savara Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)

Table 67. Savara Recent Development

Table 68. Beyond Air Company Details

Table 69. Beyond Air Business Overview

Table 70. Beyond Air Nontuberculous Mycobacterium Treatment Product

Table 71. Beyond Air Revenue in Nontuberculous Mycobacterium Treatment Business (2020-2025) & (US$ Million)

Table 72. Beyond Air Recent Development

Table 73. Research Programs/Design for This Report

Table 74. Key Data Information from Secondary Sources

Table 75. Key Data Information from Primary Sources

Table 76. Authors List of This Report

List of Figures

Figure 1. Nontuberculous Mycobacterium Treatment Picture

Figure 2. Global Nontuberculous Mycobacterium Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nontuberculous Mycobacterium Treatment Market Share by Type: 2024 VS 2031

Figure 4. Azithromycin Features

Figure 5. Rifampin Features

Figure 6. Rifabutin Features

Figure 7. Ethambuto Features

Figure 8. Global Nontuberculous Mycobacterium Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Nontuberculous Mycobacterium Treatment Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Pharmacies Case Studies

Figure 11. Private clinics Case Studies

Figure 12. Drug Stores and Retail Pharmacy Case Studies

Figure 13. E-commerce Case Studies

Figure 14. Nontuberculous Mycobacterium Treatment Report Years Considered

Figure 15. Global Nontuberculous Mycobacterium Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nontuberculous Mycobacterium Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nontuberculous Mycobacterium Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Nontuberculous Mycobacterium Treatment Market Share by Players in 2024

Figure 19. Global Top Nontuberculous Mycobacterium Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nontuberculous Mycobacterium Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nontuberculous Mycobacterium Treatment Revenue in 2024

Figure 21. North America Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)

Figure 23. United States Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)

Figure 27. Germany Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Share by Region (2020-2031)

Figure 35. China Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nontuberculous Mycobacterium Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nontuberculous Mycobacterium Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Insmed Incorporated Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)

Figure 51. RedHill Biopharma Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)

Figure 52. Novoteris Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)

Figure 53. Savara Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)

Figure 54. Beyond Air Revenue Growth Rate in Nontuberculous Mycobacterium Treatment Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Mycobacterium Tuberculosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Active Tuberculosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti tuberculosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Antituberculosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Hodgkin Lymphoma Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Myocarditis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Invasive Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Tuberculosis Vaccine Market Research Report 2025

Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic BCG Vaccines Market Insights Forecast to 2030

Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Myotubular Myopathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions